A brief history of and future prospects for pneumococcal vaccination in Malaysia

Pneumonia

Review

Lokman H. Sulaiman¹  Alex J. J. Lister²  Evelin Dombay²  Stuart C. Clarke³  David W. Cleary⁴ 

[1] Centre for Environment and Population Health, Institute for Research, Development, and Innovation, International Medical University, Kuala Lumpur, Malaysia;Department of Community Medicine, School of Medicine, International Medical University, Kuala Lumpur, Malaysia;Faculty of Medicine, Institute for Life Sciences, University of Southampton, Southampton, UK;Faculty of Medicine, Institute for Life Sciences, University of Southampton, Southampton, UK;NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Trust, Southampton, UK;Global Health Research Institute, University of Southampton, Southampton, UK;School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia;Centre for Translational Research, Institute for Research, Development, and Innovation, International Medical University, Kuala Lumpur, Malaysia;Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK;NIHR Birmingham Biomedical Research Centre, Institute of Translational Medicine, Birmingham, Birmingham, UK;

关键词: Pneumococcal disease;    Pneumococcal vaccination;    Malaysia;    Vaccination policy;    Pneumonia;   

DOI  :  10.1186/s41479-023-00114-8

 received in 2023-03-21, accepted in 2023-07-30,  发布年份 2023

来源: Springer

【 摘 要 】

Pneumococcal pneumonia remains a significant global public health issue. Malaysia has recently added the 10 valent pneumococcal conjugate vaccine to its national immunisation programme. Data on pneumococcal serotype epidemiology is vital for informing national vaccination policy. However, there remains a lack of representative population-based pneumococcal surveillance in Malaysia to help both the assessment of vaccine effectiveness in the country and to shape future vaccine policy. This review explores the history of pneumococcal vaccination, the burden of pneumococcal disease in Malaysia, and offers an insight into the prospects for reducing pneumococcal disease in Malaysia.

【 授权许可】

CC BY   
© BioMed Central Ltd., part of Springer Nature 2023

【 图 表 】

Fig. 1

Fig. 1